Stamford, CT -- (SBWIRE) -- 01/16/2014 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Clean Diesel Technologies, Inc. (NASDAQ:CDTI), Cereplast Inc (OTCMKTS:CERP), Hemispherx BioPharma, Inc (NYSEMKT:HEB), DARA Biosciences Inc (NASDAQ:DARA).
Clean Diesel Technologies, Inc. (NASDAQ:CDTI) opened its last trade at the price of $3.12. Its closing price was $2.98 after losing -8.87% for the day. The company traded with the total volume of 2.24 million shares, while its average trading volume remained 505,511.00 shares. The beta of this stock stands at 2.18. Clean Diesel Technologies, Inc. engages in the manufacture and distribution of heavy duty diesel and light duty vehicle emissions control systems and products to automakers, integrators, and retrofitters worldwide. The company operates in two divisions, Heavy Duty Diesel Systems and Catalyst.
Has CDTI Found The Bottom and Ready To Move Up? Find Out Here
Cereplast Inc (OTCMKTS:CERP) percentage change plunged -7.59% to close at $0.0073 with the total traded volume of 7.39 million shares, along with average volume of 17.36 million shares. The 52 week range of the stock remained $0.00 - $0.07, while its day lowest price was $0.01. The share price hit the day highest price of $0.01. Cereplast, Inc. develops and commercializes bio-based resins. It provides Cereplast Compostables resins, which are compostable, bio-based, and ecologically sound substitutes for petroleum-based plastics targeting compostable bags, single-use food service products, and packaging applications.
Has CERP Found The Bottom And Ready To Gain Momentum? Find Out Here
Hemispherx BioPharma, Inc (NYSEMKT:HEB) traded on volume of 11.39 million shares in the last session against average volume of 2.98 million shares. The company started its trading session with the price of $0.50 and closed at $0.399 by scoring -7.21%. Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
Why Should Investors Buy HEB After the Recent Fall? Just Go Here and Find Out
DARA Biosciences Inc (NASDAQ:DARA) started its last trading session with the price of $0.76 and closed at $0.721 by scoring -5.71%. The stock traded with total volume of 3.10 million shares, while the average trading volume remained 1.52 million shares. The beta value of this stock stands at 1.50. Day range for the stock was $0.65 - $0.77. DARA BioSciences, Inc., a development stage biopharmaceutical company, engages in the development and commercialization of oncology treatment and supportive care pharmaceutical products in the United Sates. It offers Soltamox for the chronic treatment of breast cancer or for cancer prevention in certain susceptible breast cancer subgroups.
Will DARA Get Buyers Even After The Recent Rally? Find Out Here
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)